Pharmacoeconomics and Health Economics

Pharmacoeconomics and Health Economics by Dr. Oestreich + Partner

In the area of health economics and pharmacoeconomics Dr. Oestreich + Partner GmbH provides a complete range of services with regard to optimisation of the cost-benefit ratio of products and, for example, the measurement of patient quality of life under specific therapy and care conditions. We provide complete solutions in these areas for pharmaceutical companies, manufacturers of medical devices and diagnostics, health care institutions and other organisations. The service package includes the provision of interactive software solutions and the development of networks and software. Moreover, in the area of pharmacoeconomics Dr. Oestreich + Partner GmbH draws on long-standing experience in the measurement of product life cycles.

Our services in the area of health economics and pharmacoeconomics provide our clients with the means of reaching reliable conclusions as to the cost-effectiveness of their products. Conclusions which are based on empirical research and interdisciplinary methodologies.

Pharmacoeconomics and Health Economics – a Broad Range of Activities

To support our customers we also provide services in the economic evaluation of medicinal products and medical devices, such as cost unit-based programmes in medical and institutional care using retrospective and prospective designs. In addition, we manage long-term projects on clinical outcomes and the economics of health care. These include project planning, financial controlling, and the statistical analysis and reporting of clinical diagnostics, plus treatment and cost-benefit analyses. The provision of telemedicine systems to record compliance, efficacy and safety of treatment measures for patient self-monitoring also comprises part of our services in the areas of pharmacoeconomics and health economics.

Customer satisfaction and compliance with international standards are always very much in the foreground of our service offering and, of course, apply to our services provided in the areas of pharmacoeconomics and health economics and pharmacoeconomics. An experienced and multidisciplinary team of specialists ensures that all projects are managed in a reliable and flexible manner. Moreover, we draw on a large network of local partners, which enables the management of any number of projects and provides for high cost efficiency.

 Learn more about our services in pharmacoeconomics and health economics - Click here! 


EMA Pharmacovigilance
Health care studies
Observational studies
EMA Pharmacovigilance
Medical Biometrics
Approval of Medical Devices
Pharmacovigilance
Clinical Investigators
Clinical Trials
GCP Legislation
GCP - Good Clinical Practice
ICH GCP E6
GCP Guidelines
GCP Compliance
BfArM GCP
Clinical Research Organisation
Contract Research Organisation
PSUR
PSURs
Pharmacoeconomics, Health
Pharmacoeconomic studies
Pharmacoeconomics
Patient Monitoring
Monitoring Clinical Trials
Clinical Monitor
Marketing Authorisation
Medicinal Product Approval
Drug safety
Data management plan
Clinical development
Monitoring investigators
Non-interventional studies (NIS)
Patient recruitment
Phase IV studies
Investigator audit
Investigator qualification
Investigator selection

EMA Pharmacovigilance · Health care studies · Observational studies · EMA Pharmacovigilance · Medical Biometrics · Approval of Medical Devices · Pharmacovigilance · Clinical Investigators · Clinical Trials · GCP Legislation · GCP - Good Clinical Practice · ICH GCP E6 · GCP Guidelines · GCP Compliance · BfArM GCP · Clinical Research Organisation · Contract Research Organisation · PSUR · PSURs · Pharmacoeconomics, Health · Pharmacoeconomic studies · Pharmacoeconomics · Patient Monitoring · Monitoring Clinical Trials · Clinical Monitor · Marketing Authorisation · Medicinal Product Approval · Drug safety · Data management plan · Clinical development · Monitoring investigators · Non-interventional studies (NIS) · Patient recruitment · Phase IV studies · Investigator audit · Investigator qualification · Investigator selection